1. Home
  2. HROW vs IMKTA Comparison

HROW vs IMKTA Comparison

Compare HROW & IMKTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harrow Inc.

HROW

Harrow Inc.

HOLD

Current Price

$34.10

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo Ingles Markets Incorporated

IMKTA

Ingles Markets Incorporated

HOLD

Current Price

$88.53

Market Cap

1.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
HROW
IMKTA
Founded
1998
1963
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Food Chains
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.6B
IPO Year
N/A
1994

Fundamental Metrics

Financial Performance
Metric
HROW
IMKTA
Price
$34.10
$88.53
Analyst Decision
Strong Buy
Analyst Count
8
0
Target Price
$71.14
N/A
AVG Volume (30 Days)
924.6K
114.9K
Earning Date
01-01-0001
05-06-2026
Dividend Yield
N/A
0.76%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$5,334,032,609.00
Revenue This Year
$44.68
N/A
Revenue Next Year
$40.71
N/A
P/E Ratio
N/A
$15.91
Revenue Growth
N/A
N/A
52 Week Low
$20.85
$59.09
52 Week High
$54.98
$90.49

Technical Indicators

Market Signals
Indicator
HROW
IMKTA
Relative Strength Index (RSI) 27.80 63.43
Support Level $30.55 $68.58
Resistance Level $40.64 $90.24
Average True Range (ATR) 2.54 2.81
MACD -1.45 -0.39
Stochastic Oscillator 2.31 84.23

Price Performance

Historical Comparison
HROW
IMKTA

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

About IMKTA Ingles Markets Incorporated

Ingles Markets Inc is a U.S.-based company that is principally engaged in operating a supermarket chain. The company operates the business in the southeast United States, mainly in Georgia, North Carolina, South Carolina, and Tennessee, with a few stores in Virginia and Alabama as well. The company locates its stores majorly in suburban areas, small towns, and neighborhood areas. It offers a broad range of goods, including food products, pharmacies, health and beauty care products, and general merchandise. The retail business contributes the majority of the company's revenue. The company's real estate ownership of a material portion of total stores enables it to generate rental income.

Share on Social Networks: